Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 6 de 6
1.
Article En | MEDLINE | ID: mdl-38719570

BACKGROUND: The predominant trend in cancer treatment now leans towards outpatient care, placing the responsibility of pain management largely on the patients themselves. Moreover, a significant portion of treatment for advanced cancer occurs in the home environment, so patient self-management becomes increasingly crucial for the effective treatment of cancer pain. OBJECTIVES: To map self-management for pain in patients with cancer at all phases of the disease before examining the potential of pain self-care interventions for ill patients with cancer. METHODS: A search was conducted on six electronic databases to locate studies published in English, from 2013 to 2023. We followed Arskey and O'Malley's Scoping Reviews guidelines. RESULTS: This study thoroughly examined the provision of cancer pain self-management by healthcare professionals and identified four intervention types from 23 studies. Education emerged as the most prevalent form of self-management for cancer pain. CONCLUSION: Guiding patients in managing their pain effectively, starting from their hospitalisation and extending to their discharge.

2.
J Vasc Nurs ; 42(1): 60-64, 2024 Mar.
Article En | MEDLINE | ID: mdl-38555179

The purpose of this study was to assess the efficacy of early cognitive training in enhancement of cognitive function in stroke patients. This research used a quasi-experimental design, 45 patients were divided into two groups, and sequential sampling was employed. The experimental group (n = 22) received two weeks of early cognitive training six times per week, whereas the control group (n = 23) received regular hospital care. The Indonesian version of the Montreal Cognitive Assessment was used to evaluate cognitive function (MoCA-Ina). On the second day of therapy, pre-test data were taken, and post-test data were gathered after the intervention. Statistical test outcomes The MoCA-Ina score changed considerably between the intervention and control groups (p = 0.000 and p = 0.003, respectively). Several tests determined that the score was p = 0.017; the score after the intervention was substantially different between the two groups. It means cognitive function improves after exercise in the acute phase.


Cognition , Stroke , Humans , Exercise/psychology , Stroke/complications , Stroke/therapy , Exercise Therapy , Mental Status and Dementia Tests
3.
Nutrients ; 15(3)2023 Jan 21.
Article En | MEDLINE | ID: mdl-36771272

Hyperlipidaemia is causally related to coronary artery diseases (CAD) and peripheral artery diseases (PAD) in people with Diabetes Mellitus (DM). An in vivo study confirmed that virgin coconut oil (VCO) could maintain levels of lipids in the blood as effectively as conventional therapy. Therefore, this study aimed to determine the effect of VCO on the lipid profiles and ankle-brachial index (ABI) of patients with DM. In this experimental study with pre- and post-test design and a control group, the participants were selected purposively. The ABI was evaluated on the first visit. Baseline lipid profile readings were taken. Each participant took 1.2 mL/kgBW of VCO daily and divided it into three doses. After 30 days of taking VCO, laboratory examinations and ABI were repeated, and adverse events were evaluated. The dependent t-test and Wilcoxon sign rank test with a significance level of α ≤ 0.05 showed a significant decrease in low-density lipoprotein (LDL) (p = 0.002), a significant increase in high-density lipoprotein (HDL) levels (p = 0.031), a significant decrease in energy intake (p = 0.046) and cholesterol intake (p = 0.023) at the endpoint in the VCO group. In conclusion, this therapy is beneficial for maintaining lipid profile when combined with dietary therapy. Future studies should investigate the duration and dosage of VCO on patients to maintain lipid-linked protein.


Diabetes Mellitus , Hyperlipidemias , Humans , Coconut Oil , Diet , Diabetes Mellitus/drug therapy , Lipoproteins, LDL , Hyperlipidemias/drug therapy
4.
Breast Dis ; 40(S1): S129-S133, 2021.
Article En | MEDLINE | ID: mdl-34092586

OBJECTIVE: The purpose of this study is to determine the effect of Apis dorsata Honey as a complementary therapy on IL-37 levels and fatigue in breast cancer patients undergoing chemotherapy. METHOD: The study used a quasi-experimental pretest-posttest design with a control group. A total of 30 subjects were recruited using a concurrent sampling technique. The intervention group consisted of 15 subjects who received oral honey at a dose of 13 ml (1 tablespoon × 3) for 15 days, and the control group consisted of 15 subjects. The groups' samples were chosen at random. The Fatigue Symptom Inventory (FSI) was used to assess the side effects of chemotherapy. RESULTS: Although the effect of Apis dorsata Honey on IL-37 levels was not statistically significant (p > 0.05), the group given honey experienced a clinically significant increase in IL-37 levels, with a mean before (632.37514.93) and post (632.37514.93). (1,003.021,248.88). Fatigue decreased statistically significantly in the group given mean honey values prior to 13.205.59 and after 11.805.07 (p = 0.004). CONCLUSION: Honey administration increases IL-37 levels clinically, though the increase is not statistically significant. Giving honey to patients with breast cancer can help alleviate fatigue caused by chemotherapy.


Antineoplastic Agents/adverse effects , Breast Neoplasms/drug therapy , Complementary Therapies/methods , Fatigue/etiology , Honey , Interleukin-1/blood , Administration, Oral , Adult , Animals , Bees , Complementary Therapies/standards , Congresses as Topic , Drug Therapy , Fatigue/therapy , Female , Humans , Middle Aged , Non-Randomized Controlled Trials as Topic
5.
Breast Dis ; 40(S1): S97-S101, 2021.
Article En | MEDLINE | ID: mdl-34057124

BACKGROUND: The overproduction of interleukin-6 (IL-6) in breast cancer cases can aggravate metastases. In comparison, the production of T lymphocytes plays a role in suppressing the development of tumor cells. Honey as a complementary therapy is expected to reduce the overproduction of IL-6 and facilitate the production of T lymphocytes in breast cancer cases. OBJECTIVE: This study aims to determine the effect of Dorsata honey (DH) as a complementary therapy to IL-6 levels and T lymphocytes of post-chemotherapy in breast cancer. METHODS: This study was a quasi-experimental approach that employed a pretest-posttest group control design. As many as 30 post-chemotherapy breast cancer patients at the Central Hospital in Eastern Indonesia were randomly selected into a control group of 15 participants. Additionally, an intervention group of 15 participants was given DH orally three times a day at a dose of 15 ml. The blood sample was taken two times, day 0 of the chemotherapy and day 16 (post-chemotherapy). The level of IL-6 was measured by ELISA, while the data were analyzed by Wilcoxon, independent T-test, and Mann-Whitney test. RESULTS: The results showed that DH did not significantly affect IL-6 levels (p = 0.17). However, there was an increase in T lymphocyte levels with statistically significant differences (p = 0.01) in intervention groups. There was no difference in Il-6 and T lymphocyte levels between the intervention and control groups (p > 0.05). CONCLUSIONS: Il-6 levels tend to be constant in the intervention group. However, there is a significant increase in the T lymphocyte levels which can indirectly increase the immune system and inhibit tumor cell growth in patients with breast cancer.


Breast Neoplasms/immunology , Breast Neoplasms/therapy , Complementary Therapies/methods , Honey , Interleukin-6/immunology , T-Lymphocytes/immunology , Administration, Oral , Adult , Animals , Antineoplastic Agents/adverse effects , Antineoplastic Agents/therapeutic use , Bees , Breast Neoplasms/drug therapy , Congresses as Topic , Female , Humans , Interleukin-6/antagonists & inhibitors , Lymphocyte Count , Middle Aged , Non-Randomized Controlled Trials as Topic , T-Lymphocytes/physiology
6.
Prim Care Diabetes ; 14(2): 104-110, 2020 04.
Article En | MEDLINE | ID: mdl-31311727

AIM: This study aimed to develop an educational video for diabetic foot care in the traditional languages (Buginese and Makassarese) and evaluate the change in the patients' knowledge level after they viewed the video. METHODS: The study was performed in the following three phases: development of the video content using a Delphi Study that involved wound-care nurses, evaluation of the video's content validity by the expert panel, and evaluation of the video in the community setting by showing it to patients who spoke the traditional languages, were diagnosed with diabetes mellitus (DM), and were at risk of diabetic foot ulcers (DFU). RESULTS: Five themes emerged from the Delphi study, including observation of pre-ulcer signs, washing feet, cutting toenails, wearing socks, and checking footwear. Content validity evaluation recommended these items to be constructed for video education using the traditional languages. Evaluation in the community setting confirmed that there was a significant improvement (p = 0.001) in the knowledge about foot care among patients diagnosed with diabetes and at risk of DFU. CONCLUSION: This study produced an educational video that used the trans-cultural approach by using traditional languages to overcome the communication barrier in the process of knowledge transfer. We found that the educational video in traditional languages enhanced the patients' knowledge about diabetic foot care and thus could enable them to detect the risks for DFU and prevent DFU.


Diabetes Mellitus/therapy , Diabetic Foot/prevention & control , Health Knowledge, Attitudes, Practice , Language , Patient Education as Topic , Primary Prevention , Video Recording , Adult , Communication Barriers , Cross-Sectional Studies , Culturally Competent Care , Delphi Technique , Diabetes Mellitus/ethnology , Diabetic Foot/ethnology , Female , Health Communication , Health Knowledge, Attitudes, Practice/ethnology , Humans , Indonesia , Male , Pilot Projects , Program Development , Program Evaluation , Risk Assessment , Risk Factors , Treatment Outcome
...